november ag (NBXB) Snapshot

November AG seeks acquisitions. November AG is founding, acquiring, developing and managing companies in the field of medical technology, biotechnology and environmental technologies. November’s shares price decreased, by 1.40 cents which is 25.9% to 4 cents during the week ending October 26, 2012.

November AG reported consolidated earnings results for the nine months ended September 30, 2011. For the period, the company reported consolidated result of €6,000 or €0.001 per share on sales revenues of €2,686,000 compared to negative consolidated result of €461,000 or €0.09 loss per share on sales revenues of €2,719,000 a year ago. Operating result was negative at €19,000 compared to €457,000 a year ago. Financial results was negative at €3,000 compared to €14,000 a year ago. Result before taxes and minority interests was negative at €22,000 compared to €471,000 a year ago. Result before minority interest was negative at €1,000 compared to €461,000 a year ago. Cash used in operating activities was €284,000 compared to €166,000 a year ago. Investment in fixed assets was €41,000 compared to €50,000 a year ago.

November AG Presents at German Equity Forum, Nov-23-2011 12:45 PM. Venue: Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany. Speakers: Dirk Zurek, Chairman of Management Board and Chief Executive Officer.